Morgan Stanley Reiterates Overweight Rating for Primary Health Care Limited (PRY)
Primary Health Care Limited (ASX:PRY)‘s stock had its “overweight” rating reaffirmed by investment analysts at Morgan Stanley in a note issued to investors on Monday. They currently have a $5.76 price target on the stock.
A number of other firms have also recently commented on PRY. Analysts at Deutsche Bank reiterated a “hold” rating on shares of Primary Health Care Limited in a research note on Thursday. They now have a $4.75 price target on the stock. Separately, analysts at CIMB reiterated an “add” rating on shares of Primary Health Care Limited in a research note on Monday, August 25th. They now have a $5.57 price target on the stock.
Shares of Primary Health Care Limited (ASX:PRY) opened at 4.450 on Monday. Primary Health Care Limited has a 1-year low of A$4.360 and a 1-year high of A$5.205. The stock has a 50-day moving average of A$4.68 and a 200-day moving average of A$4.65. The company has a market cap of A$2.250 billion and a price-to-earnings ratio of 14.04.
Primary Health Care Limited acts as a medical centre operator; diagnostic imaging services; a provider of pathology, and a provider of health technology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.